Category: Biotechnology
Global Biotechnology
-
Gel Documentation Systems
... at a CAGR of 4.1% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$173.1 Million by the end of the ... Read More
-
Beta Interferon
... CAGR of 3.0% over the analysis period 2024-2030. The U.S. Market is Estimated at US$968.9 Million While China is Forecast to Grow at 4.5% CAGR The Beta Interferon market in the U.S. is estimated at ... Read More
-
Disposable Respirators
... CAGR of 4.5% over the analysis period 2024-2030. N-Series, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.5 Billion by the end of the analysis period. ... Read More
-
Interferon
... 2.8% over the analysis period 2024-2030. Interferon Beta, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$4.6 Billion by the end of the analysis period. Growth ... Read More
-
Antisense and RNAi Therapeutics
... 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. Antisense RNA, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.8 Billion by the ... Read More
-
Stem Cell Banking
... at a CAGR of 7.5% over the analysis period 2024-2030. Placental and Cord Blood Stem Cells, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$10.5 Billion ... Read More
-
Polymerase Chain Reaction Consumables
... 2030, growing at a CAGR of 3.4% over the analysis period 2024-2030. PCR Tubes, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$250.5 Million by the ... Read More
-
Cell Surface Markers
... at a CAGR of 9.4% over the analysis period 2024-2030. Antibodies, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$981.1 Million by the end of the ... Read More
-
IR Spectroscopy
... CAGR of 5.1% over the analysis period 2024-2030. Benchtop, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$647.6 Million by the end of the analysis period. ... Read More
-
Mammalian Polyclonal IgG Antibody
... 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Metabolic Markers, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$532.1 Million by the ... Read More
-
Precision Medicine
... CAGR of 8.7% over the analysis period 2024-2030. Diagnostics, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$89.0 Billion by the end of the analysis period. ... Read More
-
Precision Medicine Software
... at a CAGR of 10.0% over the analysis period 2024-2030. On-Premise, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$2.6 Billion by the end of the ... Read More
-
Protein Sequencing
... CAGR of 2.9% over the analysis period 2024-2030. Mass Spectrometry, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$973.5 Million by the end of the analysis ... Read More
-
Proteomics
... 10.1% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$49.2 Billion by the end of the analysis period. Growth in ... Read More
-
Marine Biotechnology
... CAGR of 8.4% over the analysis period 2024-2030. Biomaterials, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$6.5 Billion by the end of the analysis period. ... Read More
-
Biosensors
... 7.2% over the analysis period 2024-2030. Non-wearable, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$28.3 Billion by the end of the analysis period. Growth in ... Read More
-
Cell and Tissue Culture Supplies
... Billion by 2030, growing at a CAGR of 9.5% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$24.0 Billion by ... Read More
-
Nanotechnology
... 11.3% over the analysis period 2024-2030. Nanocomposites, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$80.8 Billion by the end of the analysis period. Growth in ... Read More
-
Industrial Enzymes
... CAGR of 4.3% over the analysis period 2024-2030. Carbohydrases, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$3.6 Billion by the end of the analysis period. ... Read More
-
Nucleic Acid Testing
... at a CAGR of 4.5% over the analysis period 2024-2030. Nucleic Acid Test Kits, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$3.7 Billion by the ... Read More
-
Research ELISA (Enzyme-Linked Immunosorbent Assay)
... Million by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. ELISA Kits, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$478.6 Million ... Read More
-
High Content Screening (HCS)
... 2030, growing at a CAGR of 9.2% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$1.0 Billion by the end ... Read More
-
Human Embryonic Stem Cell (hESC) Research
... reach US$1.4 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Regenerative Medicine, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach ... Read More
-
Laboratory Informatics
... CAGR of 8.4% over the analysis period 2024-2030. Life Science Companies, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$2.2 Billion by the end of the ... Read More
-
Nanotechnology in Drug Delivery
... 2030, growing at a CAGR of 8.0% over the analysis period 2024-2030. Nanoparticles, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$35.6 Billion by the end ... Read More
Research Assistance
